Research Areas

Evaluation of the Safety and Efficacy of An Investigational Medication in the Treatment of Chronic Pain in Patients with Diabetic Neuropathy

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and tolerability of An Investigational Medication in Subjects with Diabetic Peripheral Neuropathy, Followed by a Double-Blind Safety Extension and an Open-Label Safety Extension.

A Randomized, Double-Blind Multicenter Study Comparing the Glycemic Control Characteristics of Carvedilol and Metoprolol in Hypertensive Patients with Type II Diabetes Mellitis

An 8-Week Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Forced Titration Study to Evaluate the Efficacy and Safety of Aliskiren/Amlodipine/HCTZ Compared to Aliskiren/Amlodipine in US Minority Patients with Stage 2 Hypertension

A Prospective, Open-Label Titration Study to Evaluate the Efficacy and Safety of An Investigational Medication in Multiple Subgroups of Hypertensive Subjects who are Non-Responders to Anti-Hypertensive Monotherapy.

A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Study of the Safety and Efficacy of An Investigational Medication in Combination with Fenofibrate Compared to An Investigational Medication Alone, Fenofibrate Alone and Placebo in A Population of Type 2 Diabetic Men and Women

A 6-Week, Open-Label, Dose Comparison Study to Evaluate the Safety and Efficacy of An Investigational Medication versus Atorvastatin, Cerivastatin, Pravastatin, and Simvastatin in Subjects with Hypercholesterolemia

A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of an Investigational Extended-Release Oral Medication in Patients with Dyslipidemia

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Dose-Loading Study to Evaluate the Efficacy, Safety, and Tolerability of An Investigational Medication as Adjunctive Therapy in Subjects with Inadequately Controlled, Moderate to Severe, Chronic, Low Back Pain.

A Clinical Outcomes Study of An Investigational Medication Versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)

A Phase II Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Evaulation of the Efficacy and Safety of An Investigational Medication by High Resolution Magnetic Resonance Imaging (MRI) in Carotid Atherosclerotic Plaque

The Effect of an Investigational Medication on HbA1c levels in Type 2 Diabetic Patients, A Double-Blind, Placebo-Controlled, Randomized, Multicenter Dose-Finding and Dose Frequency Study

Repaglinide vs. Pioglitazone vs. the Combination In Type 2 Diabetes Patients: A 24-Week, Randomized, Controlled Multicenter Trial

Target Glycemic Control and the Incidence of Symptomatic Nocturnal Hypoglycemia in Insulin Naïve Subjects with Type 2 Diabetes on Oral Hypoglycemic Agents and Treated with An Investigational Insulin or NPH Human Insulin

A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Rosiglitazone Added On to a Background of an Investigational Medication in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

A Multicenter, Randomized, Open-Label, Crossover Trial in Insulin-Requiring (Type 1 and Type 2) Patients With Diabetes, Comparing the Injections with An Investigational Insulin and Disposable Pen Delivery Device and Injections with Investigational Insulin and Vial and Syringe

Proof of Concept Trial on the Antidiabetic Properties of and Investigational Medication in Patients With Type 2 Diabetes Mellitus. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study with Four Parallel Groups

Efficacy, Dose-Ranging, and Safety for and Investigational Medication in Type 2 Diabetic Subjects Inadequately Controlled on Diet, Metformin, or Sulfonylurea: A 24-Week Double-Blind Randomized, Placebo-Controlled Study

Flexibility of An Investigational Insulin Dosing. A Comparison of Safety and Efficacy of An Investigational Insulin Injected Before vs. After Meals: A Multicenter, Randomized, Open-Label, Cross-Over Design Study In Elderly Insulin-Treated Subjects With Type 2 Diabetes

Inhaled Mealtime Insulin with An Investigational Inhaled Insulin Plus Metformin & Glimepiride versus Rosiglitazone Plus Metformin & Glimepiride in Type 2 Diabetes: A 26-Week, Open Label, Multicentre, Randomized, Parallel Trial to Investigate Safety and Efficacy